# Furazolidone Quadruple Regimen Eradicate H. Pylori Infection

> **NCT06823791** · PHASE1,PHASE2 · COMPLETED · sponsor: **Liaocheng People's Hospital** · enrollment: 493 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Eradication

## Interventions

- **DRUG:** Furazolidone
- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT06823791
- **Lead sponsor:** Liaocheng People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 493 (ACTUAL)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06823791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06823791, "Furazolidone Quadruple Regimen Eradicate H. Pylori Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06823791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*